MetaCap

POMDOCTOR LIMITED (POM) vs AsiaStrategy (SORA)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

POMDOCTOR LIMITED is the larger company by market cap ($61.0 million vs $54.0 million), about 1.1 times the size. AsiaStrategy converts more of its revenue into profit, with a net margin of 111.9% versus -32.7%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

POM+99.69%SORA+3.83%
+269%+109%-52%
Oct 7, 20261 yearNov 20, 2026
POM+120.13%SORA-9.58%
+143%+59%-26%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

POM versus SORA key metrics
MetricPOMSORA
Share price$1.70$2.17
Market cap$60.96M$53.95M
1-day change+5.28%-0.46%
YTD return—-28.85%
1-year return—-44.71%
P/E ratio (TTM)—4.34
EPS (TTM)$-40.31$0.50
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$57.19M$10.99M
Revenue growth (YoY)—-37.65%
Net income (latest FY)$-18.72M$12.29M
Gross margin13.07%3.47%
Operating margin-29.67%-14.35%
Net margin-32.74%111.91%
52-week high$102.42$4.49
52-week low$0.433$1.25
Distance from 52-week high-98.35%-51.67%
Average volume2.05M143.96K
Shares outstanding35.76M24.86M
Employees1657
SectorConsumer DiscretionaryIndustrials
IndustryOther Specialty StoresOther Specialty Stores

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • AsiaStrategy is more profitable, keeping 111.9 cents of every revenue dollar as net income versus -32.7 cents for POMDOCTOR LIMITED.
  • The two companies sit in different sectors: POMDOCTOR LIMITED in Consumer Discretionary and AsiaStrategy in Industrials.

About POMDOCTOR LIMITED

POM stock →

Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China.

Consumer Discretionary · Other Specialty Stores · 165 employees

About AsiaStrategy

SORA stock →

AsiaStrategy, together with its subsidiaries, engages in trading, distribution, and retail of luxury watches in Hong Kong. The company sells its products under the Omega, Cartier, Rolex, Longines, Audermars Piguet, Patek Philippe, Blancpain, Casio, Breguet, and Hublot brand names.

Industrials · Other Specialty Stores · 7 employees

POM vs SORA FAQ

Which is bigger, POMDOCTOR LIMITED or AsiaStrategy?

POMDOCTOR LIMITED (POM) is larger, with a market capitalization of $60.96M compared with $53.95M for AsiaStrategy (SORA).

Are POMDOCTOR LIMITED and AsiaStrategy in the same industry?

Yes. Both are classified in the Other Specialty Stores industry within the Consumer Discretionary sector.

More comparisons